Relevant bibliographies by topics / Doxorubicin / Books

Books on the topic 'Doxorubicin'

To see the other types of publications on this topic, follow the link: Doxorubicin.
Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 39 books for your research on the topic 'Doxorubicin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Ramji, Shairoj. Bioactivation of doxorubicin by human NADPH-cytochrome P450 reductase. Ottawa: National Library of Canada, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bengoa-Becerra, Cristina. Prospective comparison of adriamycin, vinblastine, and mitomycin C (AVM) versus adriamycin alone in the treatment of metastatic breast cancer. [New Haven: s.n.], 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Möhrer, Birgit. Aufnahme der I-123-markierten Anthrazykline Doxorubicin und Iododoxorubicin in kultivierte Mammacarzinomzellen. [s.l.]: [s.n.], 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kampe-Juzak, Eva Christina. Liposomales Doxorubicin versus Bleomycin-Vincristin: Vergleich der Effektivität beim HIV-assoziierten Kaposi Sarkom. [s.l.]: [s.n.], 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Eng, Jamei R. Pharmacogenomics of paclitaxel and doxorubicin resistance in human MCF-7 breast cancer cell lines. Sudbury, Ont: Laurentian University, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

C, Forbes, National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. A Systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer. Southampton: NCCHTA, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

C, Forbes, National Co-ordinating Centre for HTA (Great Britain), and Health Technology Assessment Programme, eds. A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer. Alton: Core Research on behalf of the NCCHTA, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Traunecker, Heidi. The biology of drug resistance in human sarcoma cells following a brief exposure to doxorubicin. Birmingham: University of Birmingham, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

German-Italian, Oncological Symposium (3rd 1984 Venice Italy). Progress in hormono- and chemotherapy. Freiburg: Kehrer, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Beaumont, Peter Orton. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Partridge, Malcolm Bruce Richard. A study of the In Vitro cytotoxicity of alkylaminoanthraquinone antitumour agents based on doxorubicin and mitozantrone. Leicester: Leicester Polytechnic, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Basra, Jaspal. A study of free radical formation in liver and heart tissue by alkylaminoanthraquinone antitumour agents based on mitozantrone and doxorubicin. Leicester: School of Pharmacy, Leicester Polytechnic, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Manisekaran, Ravichandran. Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67609-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Blais, David. The involvement of doxorubicin and paclitaxel in the activation of fas-mediated apoptosis, in MCF-7WT and MCF-7ADR human breast adenocarcinoma cells. Sudbury, Ont: Laurentian University, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Arcamone, Federico. Doxorubicin: Anticancer Antibiotics. Elsevier Science & Technology Books, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Doxorubicin: Biosynthesis, Clinical Uses and Health Implications. Nova Science Pub Inc, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Kirschstein, Margit Maria. Gezielter zytotoxischer Effekt von Transferrin-Doxorubicin-Konjugat auf Trophoblastzellen. 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kiel, Universität, ed. Aufnahme von ¹²³l-markiertem Doxorubicin in kultivierte menschliche Magenkarzinomzellen im Vergleich zur Aufnahme von ¹⁴C-markiertem Doxorubicin und ¹⁴C-markierter 2-Desoxy-D-Glucose. 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Hamburg, Universität, ed. Pharmakokinetik und Metabolisierung von Iodo-Doxorubicin: Resultate einer Phase I Studie. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Publications, ICON Health. Doxorubicin - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Overview of Doxorubicin - Clinical Use, Resistance, Side Effects, and Palliative Care [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.90961.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Age dependent toxicity of doxorubicin in children with cancer: Pharmacokinetic and pharmacodynamic evaluation. Ottawa: National Library of Canada, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kim, Kyoung-Han. The protective role of erythropoietin against doxorubicin-induced cardiomyopathy via PI3K-dependent pathway. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Shuhendler, Adam Jason. An assessment of the interaction of mitomycin C and doxorubicin in EMT6 mouse mammary tumor cells. 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Manisekaran, Ravichandran. Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics. Springer, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Manisekaran, Ravichandran. Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Johnson, George. Cancer Chronicles: Unlocking Medicine's Deepest Mystery. Penguin Random House, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Luther, Matthias Christian. Entwicklung von KDR-spezifischen Immunooliposomen mit eingeschlossenem Doxorubicin und anschliessender in-vitro-Testung am CHO-/CHO-KDR-Zellmodell. 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Böhm, Dania. Aufnahme von I-123- und Tc-99m-Doxorubicin verglichen mit Tl-201 in Daunorubicin-sensitive und -resistente Magenkarzinomzellen. 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kiel, Universität, ed. Szintigraphische Untersuchungen an Kaninchen zur in-vivo Kinetik von Jod-123-markiertem Doxorubicin mit und ohno pharmakinetisch wirksamer Zusatzmedikation. 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Primeau, Andrew J. The distribution of the anti-cancer drug doxorubicin in relation to blood vessels and regions of hypoxia in solid tumours. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Ball, Steve, and Sajid Kalathil. Adrenocortical cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0094.

Full text
Abstract:
Adrenocortical cancer (ACC) is rare and associated with poor prognosis. The incidence is estimated at 0.7–2 cases per one million. Overall survival rate at five years for ACC is 37–47%. While the pathogenesis of ACC is incompletely understood, inherited predisposition syndromes are common in childhood ACC. Clinical presentation can be with symptoms and signs of hormone excess (functional tumours), mass effects, or as an incidental radiological finding. A multidisciplinary approach combining radiology, biochemistry, and tissue-based pathology is needed to establish a diagnosis to guide a surgical approach aimed at complete resection of the tumour where possible. At present, recommended first-line therapies for advanced disease are mitotane monotherapy or etopiside, doxorubicin, and cisplatin plus mitotane. Metronomic capecitabine and gemcitabine have been used as alternatives. Adjuvant radiotherapy to the tumour bed should be considered for patients considered to be at high risk of recurrence.
APA, Harvard, Vancouver, ISO, and other styles
33

Sabersky-Müssigbrodt, Christoph. Kombinationstherapie mit 4'-O-Tetrahydropyranyl-Doxorubicin und dem recombinanten "human granulocyte-macrophage colony stimulating factor" (rh GM-CSF) bei Patientinnen mit progredient metastasierendem Mammakarzinom. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Naik, George Oliver Archibald. The pharmacokinetic analysis of a therapeutic drug interaction between a type-1 multidrug resistance modulator, valspodar (PSC 833), and an anticancer agent, doxorubicin, in patients. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Naik, George Oliver Archibald. The pharmacokinetic analysis of a therapeutic drug interaction between a type-1 multidrug resistance modulator, valspodar (PSC 833), and an anticancer agent, doxorubicin, in patients. 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Stieler, Manuela. Apoptoseinduktion durch Chemotherapeutika wie u.a. Cladribin und Gemcitabin auf CD34⁺/CD38⁺ und CD34⁺/CD38⁻ Vorläuferzellen: Selektiver protektiver Effekt von Doxorubicin und Cladribin auf hämatopoetische Stammzellen. 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Ozols, Robert F. Molecular and Clinical Advances in Anticancer Drug Resistance. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Gierlich, Thomas. Pharmakokinetik und Toxizatät des liposomalen Doxorubicins DL-1: Ergenbnisse einer Phase I Studie. 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Rocke, Angela. Aufnahme der ¹²³I und [superscript 99m]Tc markierten Anthrazykline Iododoxorubizin und Doxorubizin in kultivierten Magenkarzinomzellen nach der Kulturflaschenmethode. 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Doxorubicin' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography